Evidence has suggested that in the acute phase of anti-NMDAR encephalitis, the content of CXCL13 in CSF increased significantly, and was related to older age, presence of infection symptoms before onset, combined with teratoma, and poor immunotherapy effect. This evidence concerns the gene CXCL13 and teratoma.